These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Testosterone replacement therapy and the risk of prostate cancer. Warburton D; Hobaugh C; Wang G; Lin H; Wang R Asian J Androl; 2015; 17(6):878-81; discussion 880. PubMed ID: 25865848 [TBL] [Abstract][Full Text] [Related]
5. Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer. Golla V; Kaplan AL Curr Urol Rep; 2017 Jul; 18(7):49. PubMed ID: 28589395 [TBL] [Abstract][Full Text] [Related]
6. Testosterone Therapy Among Prostate Cancer Survivors. Nguyen TM; Pastuszak AW Sex Med Rev; 2016 Oct; 4(4):376-88. PubMed ID: 27474995 [TBL] [Abstract][Full Text] [Related]
7. Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries. Haider A; Zitzmann M; Doros G; Isbarn H; Hammerer P; Yassin A J Urol; 2015 Jan; 193(1):80-6. PubMed ID: 24980615 [TBL] [Abstract][Full Text] [Related]
8. Testosterone replacement therapy following the diagnosis of prostate cancer: outcomes and utilization trends. Kaplan AL; Trinh QD; Sun M; Carter SC; Nguyen PL; Shih YT; Marks LS; Hu JC J Sex Med; 2014 Apr; 11(4):1063-1070. PubMed ID: 24443943 [TBL] [Abstract][Full Text] [Related]
9. Registry of Hypogonadism in Men (RHYME): design of a multi-national longitudinal, observational registry of exogenous testosterone use in hypogonadal men. Rosen RC; Wu FC; Behre HM; Roehrborn CG; Schröder FH; Siami FS; Martha JF; Finn JD; Araujo AB Aging Male; 2013 Mar; 16(1):1-7. PubMed ID: 23373674 [TBL] [Abstract][Full Text] [Related]
10. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels. Blick G Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769 [TBL] [Abstract][Full Text] [Related]
12. Should testosterone replacement be offered to hypogonadal men treated previously for prostatic carcinoma? Landau D; Tsakok T; Aylwin S; Hughes S Clin Endocrinol (Oxf); 2012 Feb; 76(2):179-81. PubMed ID: 21951017 [TBL] [Abstract][Full Text] [Related]
13. Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry. Morales A BJU Int; 2011 May; 107(9):1369-73. PubMed ID: 21518230 [TBL] [Abstract][Full Text] [Related]
14. Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register. Yassin A; Salman M; Talib RA; Yassin DJ Aging Male; 2017 Jun; 20(2):125-133. PubMed ID: 28282997 [TBL] [Abstract][Full Text] [Related]
15. The Role of Testosterone Therapy in the Setting of Prostate Cancer. Rodriguez KM; Pastuszak AW; Khera M Curr Urol Rep; 2018 Jun; 19(8):67. PubMed ID: 29961247 [TBL] [Abstract][Full Text] [Related]
16. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. Pastuszak AW; Pearlman AM; Lai WS; Godoy G; Sathyamoorthy K; Liu JS; Miles BJ; Lipshultz LI; Khera M J Urol; 2013 Aug; 190(2):639-44. PubMed ID: 23395803 [TBL] [Abstract][Full Text] [Related]
17. Testosterone therapy for men at risk for or with history of prostate cancer. Morgentaler A Curr Treat Options Oncol; 2006 Sep; 7(5):363-9. PubMed ID: 16904053 [TBL] [Abstract][Full Text] [Related]